Does BRENTUXIMAB VEDOTIN Cause Hyperleukocytosis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hyperleukocytosis have been filed in association with BRENTUXIMAB VEDOTIN (ADCETRIS). This represents 0.1% of all adverse event reports for BRENTUXIMAB VEDOTIN.
6
Reports of Hyperleukocytosis with BRENTUXIMAB VEDOTIN
0.1%
of all BRENTUXIMAB VEDOTIN reports
3
Deaths
5
Hospitalizations
How Dangerous Is Hyperleukocytosis From BRENTUXIMAB VEDOTIN?
Of the 6 reports, 3 (50.0%) resulted in death, 5 (83.3%) required hospitalization.
Is Hyperleukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRENTUXIMAB VEDOTIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BRENTUXIMAB VEDOTIN Cause?
Off label use (1,370)
Neuropathy peripheral (695)
Pyrexia (693)
Febrile neutropenia (684)
Death (602)
Neutropenia (561)
Hodgkin's disease (512)
Nausea (392)
Diarrhoea (385)
Anaemia (374)
What Other Drugs Cause Hyperleukocytosis?
CYCLOPHOSPHAMIDE (55)
PREDNISONE (54)
TRETINOIN (52)
ARSENIC TRIOXIDE (49)
RITUXIMAB (49)
ACETAMINOPHEN (44)
VINCRISTINE (44)
DEXAMETHASONE (42)
PANTOPRAZOLE (38)
AMOXICILLIN (36)
Which BRENTUXIMAB VEDOTIN Alternatives Have Lower Hyperleukocytosis Risk?
BRENTUXIMAB VEDOTIN vs BREO ELLIPTA
BRENTUXIMAB VEDOTIN vs BREXANOLONE
BRENTUXIMAB VEDOTIN vs BREXPIPRAZOLE
BRENTUXIMAB VEDOTIN vs BREXUCABTAGENE AUTOLEUCEL
BRENTUXIMAB VEDOTIN vs BRIGATINIB